GC
Genitope Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by CPMG Inc, was filed 05 Jun 2007.
Genitope Corp: what insiders have been doing
This page follows insider dealings at Genitope Corp as filed with SEC (Form 4). No insider at Genitope Corp has published a filing in the past twelve months. The most recent one dates from 12 December 2008.
The full history, which starts in 2006, counts 35 purchases against 39 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
75
Thresholds
n/a
Buy Volume
€10M
35 ops. · all time
Sell Volume
€505,585
39 ops. · all time
Financial data
· cache
Last declaration on 12 December 2008
Declarations75 total
- 8,125,370 sharesCommon StockSEC:0001209191-08-065641:0
- 32,588 shares@ US$3.6657Common StockSEC:0001209191-07-035440:0Canonical exit: 30 Aug 2007 (T+90)
- 150,510 shares@ US$3.7147Common StockSEC:0001209191-07-035440:1Canonical exit: 3 Sept 2007 (T+90)
- 300,021 shares@ US$2.88Common StockSEC:0001209191-07-033269:0Canonical exit: 31 Dec 2006 (T+90)
- 165,917 shares@ US$2.4862Common StockSEC:0001209191-07-033267:0Canonical exit: 19 Nov 2006 (T+90)
- 105,229 shares@ US$3.6107Common StockSEC:0001209191-07-032918:0Canonical exit: 20 Aug 2007 (T+90)
- 61,154 shares@ US$3.6456Common StockSEC:0001209191-07-032918:1Canonical exit: 21 Aug 2007 (T+90)
- 52,325 shares@ US$3.5917Common StockSEC:0001209191-07-032918:2Canonical exit: 22 Aug 2007 (T+90)
- 550,000 shares@ US$3.5988Common StockSEC:0001209191-07-029763:0Canonical exit: 7 Aug 2007 (T+90)
- 171,000 shares@ US$3.45Common StockSEC:0001209191-07-029763:1Canonical exit: 9 Aug 2007 (T+90)
- 211,745 shares@ US$3.418Common StockSEC:0001209191-07-029763:2Canonical exit: 9 Aug 2007 (T+90)
- 66,000 shares@ US$3.5166Common StockSEC:0001209191-07-015672:0Canonical exit: 30 May 2007 (T+90)
- 300,000 shares@ US$3.18Common StockSEC:0001209191-07-015672:1Canonical exit: 3 Jun 2007 (T+90)
- 300,000 shares@ US$3.4613Common StockSEC:0001209191-07-014402:0Canonical exit: 29 May 2007 (T+90)
- 316,202 shares@ US$3.7992Common StockSEC:0001209191-07-008200:0Canonical exit: 6 May 2007 (T+90)
- 16,500 shares@ US$3.50Common StockSEC:0001209191-07-004754:0Canonical exit: 17 Apr 2007 (T+90)
- 10,000 shares@ US$3.37Common StockSEC:0001267268-06-000014:0Canonical exit: 21 Mar 2007 (T+90)
- 115,348 shares@ US$3.3024Common StockSEC:0001209191-06-066781:0Canonical exit: 21 Mar 2007 (T+90)
- 798 shares@ US$3.69Common StockSEC:0001267264-06-000006:0Canonical exit: 18 Feb 2007 (T+90)
- 300 shares@ US$3.71Common StockSEC:0001267264-06-000006:1Canonical exit: 18 Feb 2007 (T+90)
- 1,300 shares@ US$3.72Common StockSEC:0001267264-06-000006:2Canonical exit: 18 Feb 2007 (T+90)
- 5,102 shares@ US$3.73Common StockSEC:0001267264-06-000006:3Canonical exit: 18 Feb 2007 (T+90)
- 400 shares@ US$3.72Common StockSEC:0001267264-06-000006:4Canonical exit: 18 Feb 2007 (T+90)
- 5,801 shares@ US$3.73Common StockSEC:0001267264-06-000006:5Canonical exit: 18 Feb 2007 (T+90)
- 500 shares@ US$3.74Common StockSEC:0001267264-06-000006:6Canonical exit: 18 Feb 2007 (T+90)
25 of 75 declarations
About Genitope Corp
Genitope Corp is a company focused on developing gene therapies for the treatment of serious diseases. It is listed on NASDAQ under the symbol XNAS.
